17.75
전일 마감가:
$18.27
열려 있는:
$18.09
하루 거래량:
3.21M
Relative Volume:
1.01
시가총액:
$5.06B
수익:
$1.19B
순이익/손실:
$117.80M
주가수익비율:
43.26
EPS:
0.4103
순현금흐름:
$92.48M
1주 성능:
-3.64%
1개월 성능:
+14.81%
6개월 성능:
-7.46%
1년 성능:
+58.06%
소테라헬스 Stock (SHC) Company Profile
명칭
Sotera Health Co
전화
440-262-1410
주소
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SHC
Sotera Health Co
|
17.75 | 5.21B | 1.19B | 117.80M | 92.48M | 0.4103 |
|
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
|
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
소테라헬스 Stock (SHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | 재개 | RBC Capital Mkts | Outperform |
| 2025-12-18 | 개시 | William Blair | Outperform |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-05-05 | 업그레이드 | Goldman | Neutral → Buy |
| 2024-12-06 | 개시 | Goldman | Neutral |
| 2024-05-21 | 개시 | Piper Sandler | Neutral |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-03-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-01-11 | 업그레이드 | Barclays | Underweight → Overweight |
| 2023-01-11 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-09-20 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-09 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-03-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-14 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Citigroup | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | JP Morgan | Overweight |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | RBC Capital Mkts | Outperform |
모두보기
소테라헬스 주식(SHC)의 최신 뉴스
Statutory Profit Doesn't Reflect How Good Sotera Health's (NASDAQ:SHC) Earnings Are - 富途牛牛
Sotera Health Co (SHC) Stock Up 5.2% but GF Value Says Overvalued -- GF Score: 74/100 - GuruFocus
How Investors Are Reacting To Sotera Health (SHC) Being Dropped From Key Russell Growth Indices - simplywall.st
3 Reasons SHC is Risky and 1 Stock to Buy Instead - Yahoo Finance
Sotera Health (SHC) Could Be 12% Undervalued As Russell Index Removal Stirs Volatility - simplywall.st
Sotera Health stock edges higher. MarketBeat highlights extended-hours gains - ad-hoc-news.de
Is Sotera Health Company (SHC) A Good Stock To Buy Now? - Yahoo Finance
Sotera Health Co (SHC) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Sotera Health shares, sector peers and risk management in focus - ad-hoc-news.de
Sotera Health Co (SHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
SHC Maintained by Barclays -- Price Target Raised to $19.00 - GuruFocus
Sotera Health Co (SHC) Institutional Confidence - TradingKey
Sotera Health Co (SHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sotera Health Co (SHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sotera Health Co (SHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sotera Health Co (SHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sotera Health Co (SHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sotera Health Co Stock (US8293551086): Earnings Metrics In Focus After Recent Quarterly Update - AD HOC NEWS
Sotera Health (SHC) Valuation After Goldman Coverage Legal Clarity And Earnings Beat - simplywall.st
Sotera Health Co stock (US8293551086): investors eye litigation overhang and growth in sterilization - AD HOC NEWS
Did Goldman Sachs’ Legal-Risk Reassessment Just Shift Sotera Health's (SHC) Investment Narrative? - simplywall.st
SHC Initiates Coverage On by Goldman Sachs -- Price Target Annou - GuruFocus
Goldman Sachs initiates Sotera Health stock with buy rating on durable model - Investing.com
Sotera Health Co stock (US8293551086): Nasdaq-listed sterilization group in focus after recent earni - AD HOC NEWS
SHCSotera Health Co Forecast, Target Price - Finviz
Sotera Health (SHC) director Ann R. Klee granted 14,970 RSUs as equity award - Stock Titan
Sotera Health (SHC) CEO awarded large RSU and performance SAU grants - Stock Titan
Sotera Health (NYSE: SHC) CEO Alton Shader files initial insider Form 3 - Stock Titan
Sotera Health (SHC) director awarded 14,970 RSUs as equity compensation - Stock Titan
Sotera Health (SHC) director Sean Cunningham receives 14,970 RSU equity grant - Stock Titan
Sotera Health (SHC) director Karen Flynn granted 14,970 RSUs as board compensation - Stock Titan
Sotera Health (SHC) director receives 14,970 RSUs in equity grant - Stock Titan
Sotera Health (SHC) awards 14,970 RSUs to director Vincent Petrella - Stock Titan
Sotera Health (SHC) director gets 14,970 RSUs, now holds 95,751 - Stock Titan
Sotera Health (SHC) director Christopher Simon receives 14,970 RSU award - Stock Titan
Sotera Health (SHC) director awarded 14,970 RSUs, now holds 89,882 shares - Stock Titan
The Bull Case For Sotera Health (SHC) Could Change Following Term Loan Refinancing At Lower Interest Margin - Yahoo Finance
A Look At Sotera Health (SHC) Valuation After Strong Q1 Beat And Upgraded Full Year Outlook - Yahoo Finance
Sotera Health’s SWOT analysis: legal wins reshape stock outlook By Investing.com - Investing.com Canada
Sotera Health’s SWOT analysis: legal wins reshape stock outlook - Investing.com
Sotera Health names new CEO in planned leadership transition - MSN
Sotera Health shareholders elect directors and approve executive pay at annual meeting - Investing.com Australia
Sotera Health (NASDAQ: SHC) investors back directors, pay and auditor - Stock Titan
Q1 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Sotera Health Co Annual Shareholders Meeting Transcript - GuruFocus
DoubleVerify, Sotera Health, PROG Holdings: Stocks Under $50 to Approach With CautionNews and Statistics - IndexBox
Sotera Health (SHC) amends First Lien Credit Agreement and reprices term loans - Stock Titan
3 Stocks Under $50 We Find Risky - Yahoo Finance
1 of Wall Street’s Favorite Stock Worth Your Attention and 2 We Find Risky - Yahoo Finance
JP Morgan Maintains Sotera Health (SHC) Neutral Recommendation - MSN
소테라헬스 (SHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):